AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 22576074 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.15 mg/kg intravenous ketamine
Number of subjects: 80
Study 22576074 — intervention group
Group type: COMPARATOR
Intervention: 100 mg rectal diclofenac suppository
Number of subjects: 80
Study 20490573 — intervention group
Group type: EXPERIMENTAL
Intervention: Gabapentin 600 mg (G2) or placebo (G1 and G3) administered 2 hours prior to surgery and in the PACU
Number of subjects: 82
Study 20490573 — intervention group
Group type: COMPARATOR
Intervention: Placebo (G1 and G2)
Number of subjects: 82
Study 20490573 — intervention group
Group type: EXPERIMENTAL
Intervention: Gabapentin 600 mg (G3)
Number of subjects: 82
Study 17992347 — intervention group
Group type: EXPERIMENTAL
Intervention: HAART
Number of subjects: 371
Study 16239358 — intervention group
Group type: EXPERIMENTAL
Intervention: Pradefovir 10 mg
Number of subjects: 0
Study 16239358 — intervention group
Group type: EXPERIMENTAL
Intervention: Pradefovir 30 mg
Number of subjects: 0
Study 16239358 — intervention group
Group type: EXPERIMENTAL
Intervention: Pradefovir 60 mg
Number of subjects: 0
Study 16239358 — intervention group
Group type: EXPERIMENTAL
Intervention: Food effect at 30 mg
Number of subjects: 0
Study 11194526 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 g of American ginseng (AG)
Number of subjects: 10
Study 11194526 — intervention group
Group type: EXPERIMENTAL
Intervention: 6 g of American ginseng (AG)
Number of subjects: 10
Study 11194526 — intervention group
Group type: EXPERIMENTAL
Intervention: 9 g of American ginseng (AG)
Number of subjects: 10
Study 11194526 — intervention group
Group type: COMPARATOR
Intervention: Placebo (0 g of AG)
Number of subjects: 10
Study 9278463 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium and Vitamin D supplementation (500 mg of calcium plus 700 IU of vitamin D3 per day)
Number of subjects: 389
Study 9278463 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 389
Study 8299295 — intervention group
Group type: EXPERIMENTAL
Intervention: Cisapride
Number of subjects: 2
Study 8299295 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2
Study 3104960 — intervention group
Group type: EXPERIMENTAL
Intervention: Diazepam 10 mg
Number of subjects: 12
Study 3104960 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 3050678 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5% timolol maleate
Number of subjects: 47
Study 3050678 — intervention group
Group type: COMPARATOR
Intervention: 1% epinephrine
Number of subjects: 47
Study 31035953 — intervention group
Group type: EXPERIMENTAL
Intervention: Syphilis infection testing
Number of subjects: 277
Study 31035953 — intervention group
Group type: EXPERIMENTAL
Intervention: History of coerced sexual intercourse
Number of subjects: 277
Study 31035953 — intervention group
Group type: EXPERIMENTAL
Intervention: Sub-district of residence
Number of subjects: 277
Study 28637449 — intervention group
Group type: EXPERIMENTAL
Intervention: Interpersonal Counseling (IPC) provided by community health workers, 3-4 sessions over 2 months
Number of subjects: 86
Study 28637449 — intervention group
Group type: COMPARATOR
Intervention: Enhanced treatment as usual (E-TAU), facilitated referral to specialized mental health care
Number of subjects: 86
Study 26005188 — intervention group
Group type: EXPERIMENTAL
Intervention: TT with FES applied to GM and TA muscles (TTFES-GM+TA group)
Number of subjects: 36
Study 26005188 — intervention group
Group type: EXPERIMENTAL
Intervention: TT with FES applied to TA muscle (TTFES-TA group)
Number of subjects: 36
Study 26005188 — intervention group
Group type: COMPARATOR
Intervention: TT only (control group)
Number of subjects: 36
Study 23052650 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin A supplementation with antibiotics (n=17)
Number of subjects: 61
Study 23052650 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin E supplementation with antibiotics (n=18)
Number of subjects: 61
Study 23052650 — intervention group
Group type: COMPARATOR
Intervention: Control group (antibiotics only; n=25)
Number of subjects: 61
Study 22077144 — intervention group
Group type: EXPERIMENTAL
Intervention: Apixaban (2.5 mg orally twice daily for 30 days)
Number of subjects: 4495
Study 22077144 — intervention group
Group type: COMPARATOR
Intervention: Enoxaparin (40 mg subcutaneously once daily for 6 to 14 days)
Number of subjects: 4495
Study 22077144 — intervention group
Group type: EXPERIMENTAL
Intervention: Apixaban
Number of subjects: 4495
Study 22077144 — intervention group
Group type: COMPARATOR
Intervention: Enoxaparin
Number of subjects: 4495
Study 19386306 — intervention group
Group type: EXPERIMENTAL
Intervention: Sphincter of Oddi manometry with solid-state catheter (SSC)
Number of subjects: 30
Study 19386306 — intervention group
Group type: COMPARATOR
Intervention: Sphincter of Oddi manometry with water-perfusion triple-lumen catheter (TLC)
Number of subjects: 30
Study 16770291 — intervention group
Group type: EXPERIMENTAL
Intervention: Home visits for 1 year
Number of subjects: 171
Study 16770291 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 171
Study 14705158 — intervention group
Group type: EXPERIMENTAL
Intervention: Exposure to forbidden food (chocolate) for 24 hours
Number of subjects: 60
Study 14705158 — intervention group
Group type: COMPARATOR
Intervention: Control group (no special intervention)
Number of subjects: 60
Study 11696690 — intervention group
Group type: EXPERIMENTAL
Intervention: GIK solution
Number of subjects: 72
Study 11696690 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 72
Study 9386027 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound screening during pregnancy
Number of subjects: 3265
Study 9386027 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound exposure during pregnancy
Number of subjects: 3265
Study 7957147 — intervention group
Group type: EXPERIMENTAL
Intervention: Brisk walking programme (n = 48)
Number of subjects: 72
Study 7957147 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 24)
Number of subjects: 72
Study 2821784 — intervention group
Group type: EXPERIMENTAL
Intervention: Nedocromil sodium (2 mg)
Number of subjects: 4
Study 2821784 — intervention group
Group type: EXPERIMENTAL
Intervention: Nedocromil sodium (other doses)
Number of subjects: 4
Study 2821784 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4
Study 31240312 — intervention group
Group type: EXPERIMENTAL
Intervention: 240 g banana + 150 mL control drink
Number of subjects: 12
Study 31240312 — intervention group
Group type: COMPARATOR
Intervention: 250 mL control drink (Fresubin 2 kcal fiber, neutral flavor)
Number of subjects: 12
Study 29231539 — intervention group
Group type: EXPERIMENTAL
Intervention: GAO's neck acupuncture combined with swallowing rehabilitation
Number of subjects: 100
Study 29231539 — intervention group
Group type: COMPARATOR
Intervention: Basic pharmaceutical treatment and swallowing rehabilitation (Control group)
Number of subjects: 100
Study 29231539 — intervention group
Group type: EXPERIMENTAL
Intervention: GAO's neck acupuncture (Observation group)
Number of subjects: 100
Study 26697847 — intervention group
Group type: EXPERIMENTAL
Intervention: Donepezil (5 mg to 10 mg over 6 weeks)
Number of subjects: 54
Study 26697847 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 54
Study 23647738 — intervention group
Group type: EXPERIMENTAL
Intervention: Vx-001 + Montanide ISA51 VG (2 mg, subcutaneously)
Number of subjects: 0
Study 23647738 — intervention group
Group type: COMPARATOR
Intervention: Placebo + Montanide ISA51 VG (subcutaneously)
Number of subjects: 0
Study 23647738 — intervention group
Group type: EXPERIMENTAL
Intervention: Vx-001 + Montanide ISA51 VG
Number of subjects: 0
Study 23647738 — intervention group
Group type: COMPARATOR
Intervention: Placebo + Montanide ISA51 VG
Number of subjects: 0
Study 21200319 — intervention group
Group type: EXPERIMENTAL
Intervention: C-MB-P lock solution (0.24 M sodium citrate, 0.15% methylene blue, 0.15% methylparaben, 0.015% propylparaben)
Number of subjects: 407
Study 21200319 — intervention group
Group type: EXPERIMENTAL
Intervention: C-MB-P lock solution
Number of subjects: 407
Study 21200319 — intervention group
Group type: COMPARATOR
Intervention: Heparin (5000 units of unfractionated heparin)
Number of subjects: 407
Study 21200319 — intervention group
Group type: COMPARATOR
Intervention: Heparin
Number of subjects: 407
Study 18617304 — intervention group
Group type: EXPERIMENTAL
Intervention: On-line high-flux hemofiltration (HF)
Number of subjects: 64
Study 18617304 — intervention group
Group type: COMPARATOR
Intervention: Ultrapure low-flux hemodialysis (HD)
Number of subjects: 64
Study 16691049 — intervention group
Group type: EXPERIMENTAL
Intervention: Music therapy
Number of subjects: 36
Study 14515658 — intervention group
Group type: EXPERIMENTAL
Intervention: sevoflurane-nitrous oxide
Number of subjects: 40
Study 14515658 — intervention group
Group type: COMPARATOR
Intervention: thiopental-fentanyl
Number of subjects: 40
Study 11021731 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.25 mg butorphanol tartrate (n = 31)
Number of subjects: 151
Study 11021731 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5 mg butorphanol tartrate (n = 29)
Number of subjects: 151
Study 11021731 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.0 mg butorphanol tartrate (n = 30)
Number of subjects: 151
Study 11021731 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.0 mg butorphanol tartrate (n = 30)
Number of subjects: 151
Study 11021731 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n = 31)
Number of subjects: 151
Study 9076408 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive group advice session on F&V intake
Number of subjects: 42
Study 9076408 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-a-day health message with defined discrete portions
Number of subjects: 42
Study 8439021 — intervention group
Group type: EXPERIMENTAL
Intervention: IsoHigh group (increased isoflurane concentration to 2.6% for 10 min)
Number of subjects: 22
Study 8439021 — intervention group
Group type: COMPARATOR
Intervention: IsoLow group (continued isoflurane concentration at 1.3%)
Number of subjects: 22
Study 3518329 — intervention group
Group type: EXPERIMENTAL
Intervention: Phosphatidylserine (BS-PS) 3 X 100 mg for six weeks
Number of subjects: 42
Study 3518329 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study 30200906 — intervention group
Group type: EXPERIMENTAL
Intervention: Exposure to bright white light therapy
Number of subjects: 128
Study 30200906 — intervention group
Group type: COMPARATOR
Intervention: Exposure to dim white light (comparison group)
Number of subjects: 128
Study 26827289 — intervention group
Group type: EXPERIMENTAL
Intervention: GSK1278863 (10, 25, 50, or 100 mg)
Number of subjects: 107
Study 26827289 — intervention group
Group type: EXPERIMENTAL
Intervention: GSK1278863 (10 or 25 mg)
Number of subjects: 107
Study 26827289 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 107
Study 26827289 — intervention group
Group type: EXPERIMENTAL
Intervention: GSK1278863
Number of subjects: 107
Study 25218397 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-based cognitive therapy (MBCT)
Number of subjects: 130
Study 25218397 — intervention group
Group type: COMPARATOR
Intervention: Wait list (control group)
Number of subjects: 130
Study 22294238 — intervention group
Group type: EXPERIMENTAL
Intervention: ziprasidone
Number of subjects: 72
Study 22294238 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 72
Study 21171482 — intervention group
Group type: EXPERIMENTAL
Intervention: 24% sucrose solution
Number of subjects: 0
Study 21171482 — intervention group
Group type: COMPARATOR
Intervention: Distilled water
Number of subjects: 0
Study 17081815 — intervention group
Group type: EXPERIMENTAL
Intervention: GLP-2 (1.6 mg)
Number of subjects: 60
Study 17081815 — intervention group
Group type: EXPERIMENTAL
Intervention: GLP-2 (3.2 mg)
Number of subjects: 60
Study 17081815 — intervention group
Group type: COMPARATOR
Intervention: Saline control
Number of subjects: 60
Study 16306072 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated Management of Childhood Illness (IMCI)
Number of subjects: 0
Study 16306072 — intervention group
Group type: COMPARATOR
Intervention: Routine care
Number of subjects: 0
Study 11943529 — intervention group
Group type: EXPERIMENTAL
Intervention: Clo‐eye G (30 microg peribulbar clonidine)
Number of subjects: 60
Study 11943529 — intervention group
Group type: COMPARATOR
Intervention: CG (oral saline and peribulbar saline)
Number of subjects: 60
Study 11943529 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups (including CG)
Number of subjects: 60
Study 9585928 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined arthroscopic and radiation synovectomy
Number of subjects: 141
Study 9585928 — intervention group
Group type: COMPARATOR
Intervention: Radiation synovectomy
Number of subjects: 141
Study 9585928 — intervention group
Group type: COMPARATOR
Intervention: Arthroscopic synovectomy
Number of subjects: 141
Study 8133101 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone 0.15 mg/kg iv every 6 h for 2 days
Number of subjects: 118
Study 8133101 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone 0.15 mg/kg iv every 6 h for 4 days
Number of subjects: 118
Study 8133101 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone (both regimens)
Number of subjects: 118
Study 2697955 — intervention group
Group type: EXPERIMENTAL
Intervention: Nadolol (mean dose 87 mg/day)
Number of subjects: 2
Study 2697955 — intervention group
Group type: COMPARATOR
Intervention: Propranolol (dose 144 mg/day)
Number of subjects: 2
Study 2697955 — intervention group
Group type: EXPERIMENTAL
Intervention: Nadolol (doses less than 200 mg/day)
Number of subjects: 2
Study 2697955 — intervention group
Group type: EXPERIMENTAL
Intervention: Nadolol (doses of 240 and 280 mg/day)
Number of subjects: 2
Study 241365 — intervention group
Group type: EXPERIMENTAL
Intervention: Kö 1366 (0.0375 mg/kg)
Number of subjects: 21
Study 241365 — intervention group
Group type: EXPERIMENTAL
Intervention: Practolol (0.3 mg/kg)
Number of subjects: 21
Study 241365 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study 31330464 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief Motivational Intervention (BMI)
Number of subjects: 150
Study 31330464 — intervention group
Group type: COMPARATOR
Intervention: Relaxation training control (REL)
Number of subjects: 150
Study 28558367 — intervention group
Group type: EXPERIMENTAL
Intervention: Sinusitis Hevert SL
Number of subjects: 314
Study 28558367 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 314
Study 27005660 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbohydrate mouth rinse (CHO)
Number of subjects: 13
Study 27005660 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PLA)
Number of subjects: 13
Study 24961537 — intervention group
Group type: EXPERIMENTAL
Intervention: Fresh fruit and komatsuna (B. rapa) juice mixture
Number of subjects: 16
Study 24961537 — intervention group
Group type: COMPARATOR
Intervention: Commercial vegetable juice
Number of subjects: 16
Study 24961537 — intervention group
Group type: EXPERIMENTAL
Intervention: Both juices
Number of subjects: 16
Study 21668531 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioural intervention using a self-monitoring and reward system.
Number of subjects: 43
Study 21668531 — intervention group
Group type: COMPARATOR
Intervention: General advice on increasing dietary fibre intake (Control).
Number of subjects: 43
Study 20441243 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin (30 mg/day for at least 8 weeks)
Number of subjects: 54
Study 20441243 — intervention group
Group type: COMPARATOR
Intervention: Control (no atorvastatin therapy)
Number of subjects: 54
Study 17285097 — intervention group
Group type: EXPERIMENTAL
Intervention: Citalopram (20-40 mg daily)
Number of subjects: 291
Study 17285097 — intervention group
Group type: COMPARATOR
Intervention: Amitriptyline (50-100 mg daily)
Number of subjects: 291
Study 17285097 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 291
Study 16830653 — intervention group
Group type: EXPERIMENTAL
Intervention: BCG vaccine (105 live bacilli/per dose) with 12 months M.D.T.‐MBR
Number of subjects: 60
Study 16830653 — intervention group
Group type: EXPERIMENTAL
Intervention: Mw vaccine (1 x 108 killed bacilli as first dose and 0.5 x 108/dose in subsequent doses) with 12 months M.D.T.‐MBR
Number of subjects: 60
Study 16830653 — intervention group
Group type: COMPARATOR
Intervention: Normal saline as placebo with 12 months M.D.T.‐MBR
Number of subjects: 60
Study 11869849 — intervention group
Group type: EXPERIMENTAL
Intervention: PTCA
Number of subjects: 3634
Study 11869849 — intervention group
Group type: EXPERIMENTAL
Intervention: CABG
Number of subjects: 3634
Study 10356651 — intervention group
Group type: EXPERIMENTAL
Intervention: Buspirone 15 mg BID
Number of subjects: 289
Study 10356651 — intervention group
Group type: COMPARATOR
Intervention: Buspirone 10 mg TID
Number of subjects: 289
Study 10356651 — intervention group
Group type: EXPERIMENTAL
Intervention: Buspirone 15 mg BID and TID
Number of subjects: 289
Study 7605020 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose isoflurane (0.5 MAC)
Number of subjects: 42
Study 7605020 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose desflurane (0.5 MAC)
Number of subjects: 42
Study 7605020 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.5 MAC isoflurane
Number of subjects: 42
Study 7605020 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.5 MAC desflurane
Number of subjects: 42
Study 7605020 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose propofol (200 micrograms.kg‐1.min‐1)
Number of subjects: 42
Study 7605020 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose propofol (0.5 MAC)
Number of subjects: 42
Study 1899823 — intervention group
Group type: EXPERIMENTAL
Intervention: High-nitrogen, isotonic, enteral feeding solution (Osmolite HN, pH = 6.4) (n = 7)
Number of subjects: 13
Study 1899823 — intervention group
Group type: COMPARATOR
Intervention: 0.45 percent NaCl (pH = 5) (n = 6)
Number of subjects: 13
Study 6337699 — intervention group
Group type: EXPERIMENTAL
Intervention: Dukes' B tumors
Number of subjects: 906
Study 6337699 — intervention group
Group type: EXPERIMENTAL
Intervention: Longest diameter of the primary tumor
Number of subjects: 906
Study 6337699 — intervention group
Group type: EXPERIMENTAL
Intervention: Tumor volume analysis
Number of subjects: 906
Study 30634590 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily nutritional supplementation with vitamin D₃ (5000 IU) and phenylbutyrate (PBA, 2 × 500 mg)
Number of subjects: 197
Study 30634590 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 197
Study 30044123 — intervention group
Group type: EXPERIMENTAL
Intervention: Real-time continuous glucose monitoring (rtCGM)
Number of subjects: 316
Study 30044123 — intervention group
Group type: COMPARATOR
Intervention: Self-monitoring of blood glucose (SMBG)
Number of subjects: 316
Study 26846522 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational intervention based on spirometry results and lung age information, alongside brief health counseling (15 minutes consultation).
Number of subjects: 1000
Study 26846522 — intervention group
Group type: COMPARATOR
Intervention: Brief health counseling (5 minutes) as part of usual clinical practice.
Number of subjects: 1000
Study 28045352 — intervention group
Group type: EXPERIMENTAL
Intervention: Antidepressant prescribed to older adults without MDD
Number of subjects: 231
Study 28045352 — intervention group
Group type: COMPARATOR
Intervention: Antidepressant prescribed to older adults with MDD
Number of subjects: 231
Study 22752690 — intervention group
Group type: EXPERIMENTAL
Intervention: cilengitide 240 mg/m(2) twice weekly
Number of subjects: 140
Study 22752690 — intervention group
Group type: EXPERIMENTAL
Intervention: cilengitide 400 mg/m(2) twice weekly
Number of subjects: 140
Study 22752690 — intervention group
Group type: EXPERIMENTAL
Intervention: cilengitide 600 mg/m(2) twice weekly
Number of subjects: 140
Study 22752690 — intervention group
Group type: COMPARATOR
Intervention: docetaxel 75 mg/m(2) once every 3 weeks
Number of subjects: 140
Study 22333175 — intervention group
Group type: EXPERIMENTAL
Intervention: Etanercept 50 mg once-weekly subcutaneous injection
Number of subjects: 400
Study 22333175 — intervention group
Group type: COMPARATOR
Intervention: Placebo injection
Number of subjects: 400
Study 19587338 — intervention group
Group type: EXPERIMENTAL
Intervention: Raxibacumab (40 mg/kg)
Number of subjects: 18
Study 19587338 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study 16488485 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic antibiotics
Number of subjects: 101
Study 16488485 — intervention group
Group type: COMPARATOR
Intervention: No prophylactic antibiotics (Control)
Number of subjects: 101
Study 15084930 — intervention group
Group type: EXPERIMENTAL
Intervention: Tacrolimus (0.1+/‐0.004 mg/kg/d)
Number of subjects: 14
Study 15084930 — intervention group
Group type: EXPERIMENTAL
Intervention: CsA or Tacrolimus
Number of subjects: 14
Study 11263449 — intervention group
Group type: EXPERIMENTAL
Intervention: Thrombolysis
Number of subjects: 2508
Study 11263449 — intervention group
Group type: EXPERIMENTAL
Intervention: Early percutaneous transluminal coronary angioplasty/coronary artery bypass grafting
Number of subjects: 2508
Study 11263449 — intervention group
Group type: COMPARATOR
Intervention: Prerperfusion era (1981-1983)
Number of subjects: 2508
Study 11263449 — intervention group
Group type: COMPARATOR
Intervention: Reperfusion era (1992-1996)
Number of subjects: 2508
Study 9644480 — intervention group
Group type: EXPERIMENTAL
Intervention: Group One (worked with nurses experienced in the care of persons living with AIDS on a high‐acuity unit)
Number of subjects: 2
Study 9644480 — intervention group
Group type: COMPARATOR
Intervention: Group Two (precepted on an acute-care unit with no AIDS patients)
Number of subjects: 2
Study 7785746 — intervention group
Group type: COMPARATOR
Intervention: Nedocromil sodium 2% eye drops, administered four times daily (n=153) for VKC
Number of subjects: 2905
Study 7785746 — intervention group
Group type: COMPARATOR
Intervention: Nedocromil sodium 2% eye drops, administered four times daily (n=146) for PAC
Number of subjects: 2905
Study 7785746 — intervention group
Group type: COMPARATOR
Intervention: Nedocromil sodium 2% eye drops, administered twice daily (n=677) for SAC
Number of subjects: 2905
Study 7785746 — intervention group
Group type: COMPARATOR
Intervention: Nedocromil sodium 2% eye drops, administered four times daily for SAC
Number of subjects: 2905
Study 7785746 — intervention group
Group type: EXPERIMENTAL
Intervention: Nedocromil sodium 2% eye drops (n=295) for SAC
Number of subjects: 2905